A METHOD OF TREATMENT OF ALZHEIMER'S DISEASE AND DEVICE THEREFOR

摘要

A method and device for treating Alzheimer's disease (AD) is disclosed. The method involves the removal of circulating autoantibodies of a biochemical marker of markers, specifically human glial fibrillary acidic protein (GFAP) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in bodily fluid, preferably blood or a blood product. The invention further includes a device or process of immune system modulation effective for autoantibody removal.